XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 286,326,000 $ 28,003,000
Short-term investments 0 123,716,000
Accounts receivable 67,968,000 23,994,000
Inventory 22,312,000 5,565,000
Prepaid expenses and other current assets 10,935,000 8,947,000
Total current assets 387,541,000 190,225,000
Restricted cash equivalents 0 100,000,000
Property and equipment, net 706,000 914,000
Operating lease right-of-use assets 1,284,000 1,431,000
Intangible assets, net 252,925,000 58,954,000
Other assets 4,165,000 1,382,000
Total assets 646,621,000 352,906,000
Current liabilities:    
Accounts payable 7,416,000 8,690,000
Accrued expenses 78,544,000 54,018,000
Operating lease liabilities 1,104,000 931,000
Derivative liability 0 1,090,000
Total current liabilities 87,064,000 64,729,000
Revenue interest liability, net 0 140,351,000
Operating lease liabilities, noncurrent 617,000 1,257,000
Convertible notes payable, net 306,421,000 0
Other liabilities 3,849,000 4,532,000
Total liabilities 397,951,000 210,869,000
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of December 31, 2023 and 2022; 0 0
Common stock, $0.0001 par value; 200,000,000 shares authorized; 46,723,143 and 36,956,345 shares issued and outstanding as of December 31, 2023 and 2022 5,000 4,000
Additional paid-in capital 803,260,000 535,074,000
Accumulated deficit (556,239,000) (392,824,000)
Accumulated other comprehensive income (loss) 1,644,000 (217,000)
Total stockholders’ equity 248,670,000 142,037,000
Total liabilities and stockholders’ equity $ 646,621,000 $ 352,906,000